Increased incidence of cycloguanil resistance in malaria cases entering France from Africa, determined as point mutations in the parasites' dihydrofolate-reductase genes

Annals of Tropical Medicine and Parasitology

Volumn 93, Issue 1, 1999, Pages 25-30

  Durand, R ^a   Di Piazza, J P ^a   Longuet, C ^a   Secardin Y ^a   Clain, J ^a   Le Bras, J ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CYCLOGUANIL; DIHYDROFOLATE REDUCTASE; PROGUANIL;

AFRICA; ARTICLE; DRUG CHOICE; DRUG SENSITIVITY; FRANCE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; TRAVEL;

AFRICA; ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; FOLIC ACID ANTAGONISTS; FRANCE; GENES, PROTOZOAN; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TETRAHYDROFOLATE DEHYDROGENASE; TRIAZINES;

ANIMALIA; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032766866     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034989958762     Document Type: Article

References (20)

1. ANON. (1998). Actualisation des recommandations sanitaires pour les voyageurs. Bulletin Epidémiologique Hebdomadaire, 21, 85-92.
2. BASCO, L. K., ELDIN DE PÉCOULAS, P., WILSON, C., LE BRAS, J. & MAZABRAUD, A. (1995). Point mutation in the dihydrofolate reductase gene as the molecular basis for pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Molecular and Biochemical Parasitology, 69, 135-138.
3. CONTAMIN, H., FANDEUR, T., BONNEFOY, S., SKOURY, F., NTOUMI, F. & MERCEREAU-PUIJALON, O. (1995). PCR typing of field isolates of Plasmodium falciparum. Journal of Clinical Microbiology, 33, 944-951.
4. CONWAY, D. J., GREENWOOD, B. M. & MCBRIDE, J. S. (1991). The epidemiology of multiple-clone Plasmodium falciparum infections in Gambian patients. Parasitology, 103, 1-6.
5. COWMAN, A. F., MORRY, M. J., BIGGS, B. A., CROSS, G. A. & FOOTE, S. J. (1988). Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America, 85, 9109-9113.
6. DURAND, R., RAMILIARISOA, O., SÉCARDIN, Y., ELDIN DE PÉCOULAS, P., BASCO, L. K. & LE BRAS, J. (1997). DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 460-461.
7. ELDIN DE PÉCOULAS, P., BASCO, L. K., LE BRAS, J. & MAZABRAUD, A. (1996). Association between antifol resistance in vitro and DHFR gene point mutation in Plasmodium falciparum isolates. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 181-182.
8. LE BRAS, J. & DELORON, P. (1983). In vitro study of drug sensitivity of Plasmodium falciparum: an evaluation of a new semi-microtest. American Journal of Tropical Medicine and Hygiene, 32, 447-451.
9. LE BRAS, J., DURAND, R., DI PIAZZA, J. P., PRADINES, B., LONGUET, C. & PARZY, D. (1998). Plasmodium falciparum resistance to mefloquine, chloroquine and cycloguanil and prevention of malaria in travellers from France to Africa. Presse Médicale, 27, 1419-1423.
10. NTOUMI, F., CONTAMIN, H., ROGIER, C., BONNEFOY, S., TRAPE, J. F. & MERCEREAU-PUIJALON, O. (1995). Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. American Journal of Tropical Medicine and Hygiene, 52, 81-88.
11. OHRT, C., MIRABELLI-PRIMDAHL, L., KARNASUTA, C., CHANTAKULKIJ, S. & KAIN, K. C. (1997). Distinguishing Plasmodium falciparum treatment failures from reinfections by restriction fragment length polymorphism and polymerase chain reaction genotyping. American Journal of Tropical Medicine and Hygiene, 57, 430-437.
12. PARZY, D., DOERIG, C., PRADINES, B., RICO, A., FUSAI, T. & DOURY, J. C. (1997). Proguanil resistance in Plasmodium falciparum African isolates: assessment by mutation specific polymerase chain reaction and in vitro susceptibility testing. American Journal of Tropical Medicine and Hygiene, 57, 646-650.
13. PETERS, W. (1987). Chemotherapy and Drug Resistance in Malaria. 2nd Edn. Oxford: Academic Press.
14. PETERSON, D. S., WALLIKER D. & WELLEMS, T. E. (1988). Evidence that a point mutation in dihydrofolate-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America, 85, 9114-9118.
15. VIRIYAKOSOL, S., SIRIPOON, N., PETCHARAPIRAT, C., JARRA, W., THAITHONG, S., BROWN, K. N. & SNOU NOU, G. (1993). Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bulletin of the World Health Organization, 73, 85-95.
16. WATKINS, W. M., BRANDLING BENNETT, A. D., NEVILL, C. G., CARTER, J. Y., BORIGA, D. A., HOWELLS, R. E. & KOECH, D. K. (1988). Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 398-403.
17. WERNSDORFER, W. H. (1991). The development and spread of drug-resistant malaria. Parasitology Today, 7, 297-303.
18. WHITE, N. J. (1998). Preventing antimalarial drug resistance through combinations. Drug Resistance Updates, 1, 3-9.
19. WINSTANLEY, P. & BRECKENRIDGE, A. (1997). Therapeutics and drug development. Lancet, i, 3-4.
20. WOODEN, J., GOULD, E. E., PAULL, A. T. & SIBLEY, C. H. (1992). Plasmodium falciparum: a simple polymerase chain reaction method for differentiating strains. Experimental Parasitology, 75, 207-212.